• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BAFF 通过 BAFF-BAFF-R-PI3K-Akt 信号通路促进 T 细胞的激活。

BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway.

机构信息

Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, China; Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei, China.

Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, China; Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei, China.

出版信息

Biomed Pharmacother. 2019 Jun;114:108796. doi: 10.1016/j.biopha.2019.108796. Epub 2019 Mar 25.

DOI:10.1016/j.biopha.2019.108796
PMID:30921706
Abstract

B-cell activating factor from the tumor necrosis factor family (BAFF) has revealed its critical role in B cell proliferation and survival, as well as the pathogenesis of T-cell mediated autoimmune disease. However, the effect and molecular mechanisms of BAFF on T cell physiological function have not been fully elucidated. In this study it was seen that BAFF can promote the vitality of purified T cells, increase the proportion of CD3CD4, CD4CD25, CD4CD154, and CD4CD69 subgroups and reduce the proportion of CD4CD62L subgroups. Negating BAFF activity with Atacicept (TACI-Fc) reverses vitality and activation of T cells. Furthermore, immunofluorescence detection revealed that BAFF promotes the expression of BAFF receptor (BAFF-R) and transmembrane activator and CAML interactor (TACI) in T cells. Flow cytometry displayed that BAFF/BAFF-R activates the PI3K-Akt signaling pathway while the application of PI3K inhibitor (wortmannin) illuminated that BAFF induces T cell vitality and activation through the PI3K-Akt signaling pathway. We conclude that BAFF is involved in not only the physiology of B cells, but also that of T cells. BAFF affects physiological T-cell activation through BAFF-R-mediated activation of the PI3K-Akt signaling pathway which mirrors one of the pathological mechanisms of T cell-mediated autoimmune diseases.

摘要

B 细胞激活因子(BAFF)属于肿瘤坏死因子家族,其在 B 细胞增殖和存活以及 T 细胞介导的自身免疫性疾病发病机制中发挥着关键作用。然而,BAFF 对 T 细胞生理功能的影响及其分子机制尚未完全阐明。在本研究中发现,BAFF 可促进纯化 T 细胞的活力,增加 CD3CD4+、CD4CD25+、CD4CD154+和 CD4CD69+亚群的比例,并降低 CD4CD62L+亚群的比例。用 Atacicept(TACI-Fc)拮抗 BAFF 活性可逆转 T 细胞的活力和激活。此外,免疫荧光检测显示,BAFF 可促进 T 细胞中 BAFF 受体(BAFF-R)和跨膜激活剂和钙调神经磷酸酶相互作用因子(TACI)的表达。流式细胞术显示,BAFF/BAFF-R 激活 PI3K-Akt 信号通路,而 PI3K 抑制剂(wortmannin)的应用表明,BAFF 通过 PI3K-Akt 信号通路诱导 T 细胞活力和激活。我们的结论是,BAFF 不仅参与 B 细胞的生理功能,而且还参与 T 细胞的生理功能。BAFF 通过 BAFF-R 介导的 PI3K-Akt 信号通路的激活来影响 T 细胞的生理激活,这反映了 T 细胞介导的自身免疫性疾病的一种病理机制。

相似文献

1
BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway.BAFF 通过 BAFF-BAFF-R-PI3K-Akt 信号通路促进 T 细胞的激活。
Biomed Pharmacother. 2019 Jun;114:108796. doi: 10.1016/j.biopha.2019.108796. Epub 2019 Mar 25.
2
Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.B细胞活化因子受体在免疫性血小板减少症发病机制中的作用
J Thromb Haemost. 2016 Mar;14(3):559-71. doi: 10.1111/jth.13246. Epub 2016 Feb 17.
3
The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.BAFF/APRIL 系统在 T 细胞非依赖的针对血期疟原虫血红素的特异性反应中的作用。
Cytokine. 2018 Nov;111:445-453. doi: 10.1016/j.cyto.2018.05.037. Epub 2018 Jun 5.
4
BAFF/BAFF-R involved in antibodies production of rats with collagen-induced arthritis via PI3K-Akt-mTOR signaling and the regulation of paeoniflorin.芍药苷通过 PI3K-Akt-mTOR 信号通路及调控 BAFF/BAFF-R 对胶原诱导关节炎大鼠抗体产生的影响
J Ethnopharmacol. 2012 May 7;141(1):290-300. doi: 10.1016/j.jep.2012.02.034. Epub 2012 Feb 27.
5
BAFF upregulates CD28/B7 and CD40/CD154 expression and promotes mouse T and B cell interaction in vitro via BAFF receptor.B细胞活化因子通过B细胞活化因子受体上调CD28/B7和CD40/CD154的表达,并在体外促进小鼠T细胞与B细胞的相互作用。
Acta Pharmacol Sin. 2016 Aug;37(8):1101-9. doi: 10.1038/aps.2016.15. Epub 2016 May 16.
6
Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.特定背景下 NF-κB 和 PI3K 通路对 BAFF-R 的信号转导。
Cell Rep. 2013 Nov 27;5(4):1022-35. doi: 10.1016/j.celrep.2013.10.022. Epub 2013 Nov 14.
7
Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.肿瘤坏死因子家族B细胞活化因子(BAFF)在活动期系统性红斑狼疮T细胞中的表达:BAFF在T细胞依赖性B细胞致病性自身抗体产生中的作用。
Rheumatology (Oxford). 2007 Jul;46(7):1083-6. doi: 10.1093/rheumatology/kem097. Epub 2007 May 11.
8
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers.基于 BAFF 配体的 CAR-T 细胞靶向三种受体和多种 B 细胞癌症。
Nat Commun. 2022 Jan 11;13(1):217. doi: 10.1038/s41467-021-27853-w.
9
TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.TACI 缺失可预防 BAFF 过表达诱导的进行性小鼠狼疮肾炎。
Kidney Int. 2018 Oct;94(4):728-740. doi: 10.1016/j.kint.2018.03.012. Epub 2018 Jun 12.
10
Ligation of TLR Homologue CD180 of B Cells Activates the PI3K/Akt/mTOR Pathway in Systemic Sclerosis and Induces a Pathological Shift in the Expression of BAFF Receptors.B 细胞 TLR 同源物 CD180 的交联在系统性硬化症中激活了 PI3K/Akt/mTOR 通路,并诱导 BAFF 受体表达的病理性转变。
Int J Mol Sci. 2022 Jun 17;23(12):6777. doi: 10.3390/ijms23126777.

引用本文的文献

1
Empagliflozin targeted the immune-related gene PIK3CA in type 2 diabetes mellitus treatment: network pharmacology analysis and experimental evidence.恩格列净在2型糖尿病治疗中靶向免疫相关基因PIK3CA:网络药理学分析与实验证据
Diabetol Metab Syndr. 2025 Aug 7;17(1):320. doi: 10.1186/s13098-025-01895-2.
2
Molecular mechanisms of unique therapeutic potential of CUDC-907 for MEF2D fusion-driven BCP-ALL.CUDC-907对MEF2D融合驱动的B细胞前体急性淋巴细胞白血病独特治疗潜力的分子机制
Signal Transduct Target Ther. 2025 Jul 23;10(1):230. doi: 10.1038/s41392-025-02310-y.
3
Telitacicept combined with conventional therapy successfully treated MDA5-associated RPILD: A case report.
泰立西普联合传统疗法成功治疗了与MDA5相关的RPILD:一例病例报告。
Medicine (Baltimore). 2025 Jul 11;104(28):e43293. doi: 10.1097/MD.0000000000043293.
4
The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances.B细胞活化因子系统在自身免疫性疾病中的作用:机制、疾病影响及治疗进展
Front Immunol. 2025 Jun 6;16:1538555. doi: 10.3389/fimmu.2025.1538555. eCollection 2025.
5
Blockade of B-cell-activating factor may alleviate liver injury by restraining interferon-γ expression in T cells in experimental biliary atresia.在实验性胆道闭锁中,阻断B细胞活化因子可能通过抑制T细胞中γ干扰素的表达来减轻肝损伤。
Pediatr Surg Int. 2025 Mar 25;41(1):101. doi: 10.1007/s00383-025-06000-2.
6
A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults.在健康成年人中进行的 povetacicept(一种增强型双重 BAFF/APRIL 拮抗剂)的首次人体、随机研究,评估其安全性、药代动力学和药效学。
Clin Transl Sci. 2024 Nov;17(11):e70055. doi: 10.1111/cts.70055.
7
BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T cell responses.三阴性乳腺癌中BAFF的过表达通过诱导分泌IL-10的调节性B细胞来促进肿瘤生长,而这些调节性B细胞会抑制抗肿瘤T细胞反应。
Breast Cancer Res Treat. 2025 Jan;209(2):405-418. doi: 10.1007/s10549-024-07504-6. Epub 2024 Oct 14.
8
Tumor necrosis factor superfamily signaling: life and death in cancer.肿瘤坏死因子超家族信号转导:癌症中的生死抉择。
Cancer Metastasis Rev. 2024 Dec;43(4):1137-1163. doi: 10.1007/s10555-024-10206-6. Epub 2024 Oct 4.
9
Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis.免疫细胞表型与胆道癌风险的因果关系:来自孟德尔随机分析的证据。
Front Immunol. 2024 Jul 10;15:1430551. doi: 10.3389/fimmu.2024.1430551. eCollection 2024.
10
[Research advances on B-cell activating factor and its targeted agents in inflammatory bowel disease].[B细胞活化因子及其靶向药物在炎症性肠病中的研究进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Mar 15;26(3):315-320. doi: 10.7499/j.issn.1008-8830.2309126.